It's my understand that there will be *a* BMY/NWBO trial at UCLA, because Prins talked about it. However as I had pointed out, that does not preclude our partnering with MD Anderson on one of the other of the 3 trials, possibly with other than the two BP partners mentioned by Prins, although the 'formula' given by NWBO doesn't preclude any possible matrix of [partners X indication]. E.g. their interesting wording would allow for a second trial with BMY at MD Anderson but for a different cancer than the UCLA trial. At least that is not disallowed according to the many ways we can parse or interpret the NWBO statement, as I said. Because BMY+MD Anderson is a different 'set of partners' than BMY+UCLA. Do you disagree? As a reminder here is exactly what NWBO said about it: